ProMIS Neurosciences is a clinical-stage biotechnology company committed to the discovery and development of therapeutic antibodies selective for toxic oligomers associated with the development and progression of neurodegenerative and other misfolded protein diseases. The Company’s proprietary target discovery engine, EpiSelect™, predicts novel targets known as Disease Specific Epitopes (DSEs) on the molecular surface of misfolded proteins that cause neurodegenerative and other misfolded protein diseases, including Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), multiple system atrophy (MSA), and Parkinson’s Disease (PD). ProMIS has offices in Cambridge, Massachusetts (USA) and Toronto, Ontario (CAN).
Company Details
- Employees
- 20
- Founded
- -
- Address
- 1920 Yonge St., Suite 200,united States
- Phone
- (416) 847-6898
- ke****@****ces.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- promisneurosciences.com
- Keywords
- Biotechnology, Neurodegenerative Diseases, Alzheimer's Disease, Amyotrophic Lateral Sclerosis (ALS), Precision Molecular Targeting, Protein Folding, Neurosciences, Toxic Oligomers.
- HQ
- Toronto, Ontario
Promis™ Neurosciences, Inc. Questions
Promis™ Neurosciences, Inc.'s helpline number is (416) 847-6898
Promis™ Neurosciences, Inc.'s website is promisneurosciences.com
Promis™ Neurosciences, Inc.'s LinkedIn profile is https://www.linkedin.com/company/promis-neurosciences
Promis™ Neurosciences, Inc. has
20 employees.
View email and phone details for 20
employees at Promis™ Neurosciences, Inc..
Promis™ Neurosciences, Inc.'s industry is
Biotechnology Research
Promis™ Neurosciences, Inc.'s top competitors are
Hengrui Pharma,
Omega Funds,
3sbio Inc.,
Abivax,
Tcg Labs Soleil,
Matchpoint Therapeutics,
Dispatch Bio,
Revir Therapeutics,
Kailera Therapeutics,
Chemomab Therapeutics.
Promis™ Neurosciences, Inc.'s support email address is kevin@promisneurosciences.com
Promis™ Neurosciences, Inc.'s categories are Biotechnology Research
Promis™ Neurosciences, Inc.'s founding year is 2015
